EMFAT
HRTX icon

Emerald Mutual Fund Advisers Trust’s Heron Therapeutics HRTX Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-290,180
Closed -$2.42M – 216
2014
Q3 		$2.42M Buy
290,180
+14,580
+5% +$136K 0.23% 118
2014
Q2 		$3.4M Buy
+275,600
New +$3.29M 0.31% 101

Other funds holding HRTX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's HRTX Position: Q4 2014 in Review

Emerald Mutual Fund Advisers Trust sold out of Heron Therapeutics (HRTX) in Q4 2014, closing a stake of 290,180 shares — an estimated $2.42M sold.

Emerald Mutual Fund Advisers Trust first reported a position in HRTX in Q2 2014 and held it in 2 quarters. The position peaked at $3.4M in Q2 2014. 64 funds tracked by Wall St. Rank hold HRTX as of Q4 2014.

  • Emerald Mutual Fund Advisers Trust reported no remaining Heron Therapeutics position as of Q4 2014 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 290,180 Heron Therapeutics shares in Q4 2014, an estimated $2.42M.
  • Emerald Mutual Fund Advisers Trust first reported a position in Heron Therapeutics in Q2 2014 and held it in 2 quarters.
  • Emerald Mutual Fund Advisers Trust's Heron Therapeutics position peaked at $3.4M in Q2 2014.
  • 64 funds tracked by Wall St. Rank held Heron Therapeutics as of Q4 2014.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2014, filed 30 Jan 2015.